European Commission clears first pertuzumab biosimilar in Europe

Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence

C-Ray Therapeutics' Copper-64 (Cu-64) Type II DMF gains FDA acceptance

GSK hepatitis B therapy bepirovirsen gains FDA priority review and breakthrough designation

Johnson & Johnson IMAAVY (nipocalimab-aahu) granted FDA Priority Review as potential treatment for wAIHA

Xcovery and EVERSANA partner for US commmercialisation of lung cancer drug Ensacove

Jazz Pharmaceuticals reports FDA acceptance and Priority Review of sBLA for Ziihera (zanidatamab-hrii) combinations in first-line HER2+ locally advanced or metastatic GEA

Novartis secures European approval for remibrutinib in chronic spontaneous urticaria

Evofem signs exclusive deal to expand SOLOSEC distribution in sub-Saharan Africa

GSK secures US and EU fast-track designations for efimosfermin in MASH

AstraZeneca secures US approval for Saphnelo self-administration in lupus treatment

Abbott presents late-breaking clinical data on treating heart rhythm disorders

Novartis receives positive CHMP opinion for Itvisma in spinal muscular atrophy

Servier completes Day One Biopharmaceuticals acquisition

Cipla's AB-rated Ventolin HFA generic receives US FDA approval